Taysha Gene Therapies Announces Late-Breaking Abstract And Poster Presentation On Positive Preclinical Data For TSHA-105 Demonstrating Therapeutic Potential For The Treatment Of Epilepsy Caused By SLCA13A5 Deficiency

by | Dec 6, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.